辰欣药业 (603367)

Cisen Pharmaceutical Co., Ltd.

ASH

Tags

SSE 580 IndexPension FundsInnovative DrugsChemical PharmaceuticalsPharmaceutical ManufacturingPharmaceuticals and HealthcareHigh-Performing StocksTencent Ji'an Index

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 45275.41
  • Circulating A-Shares(W): 45275.41
  • Earnings Per Share(RMB): 0.8400
  • Net Assets Per Share(RMB): 13.5897
  • Operating Revenue(W RMB): 258377.96
  • Total Profit(W RMB): 42331.01
  • **Net Profit Attributable to Parent(W RMB) **: 38201.23
  • Net Profit Growth Rate(%): -4.05
  • Weighted Return on Equity(%): 6.2200
  • Operating Cash Flow Per Share(RMB): 1.3140
  • Undistributed Profit Per Share(RMB): 7.8206
  • Capital Reserve Per Share(RMB): 4.2734

2. Main Business

The main business covers:

  • Research, development, production, and sales of pharmaceutical products.

3. Company Basic Information

  • Company Name: Chenxin Pharmaceutical Co., Ltd.
  • Listing Date: 2017-09-29
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 16 Tongji Road, High-tech Zone, Jining City, Shandong Province
  • Website: https://www.cisen-pharma.com/
  • Company Profile: The company's predecessor was Shandong Lukang Chenxin Pharmaceutical Co., Ltd., established on November 6, 1998. On June 21, 2011, the company held its founding meeting and the first shareholders' meeting, resolving to use the audited net assets of RMB 1,224,679,731.95 as of May 31, 2011 as the base, converted into 321.23 million shares at a ratio of 3.8125:1, and restructured into Chenxin Pharmaceutical Co., Ltd. On June 30, 2011, the issuer was registered and established with the Jining City Administration for Industry and Commerce in Shandong Province, obtaining a business license with registration number 370833018004046 and a registered capital of RMB 321.23 million.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Chenxin Technology Group Co., Ltd. Corporate Entity 11889.11 26.26
2 Sichuan Kelun Pharmaceutical Co., Ltd. Corporate Entity 4533.53 10.01
3 Tianjin Qianding Enterprise Management Partnership (Limited Partnership) Corporate Entity 2653.97 5.86
4 Shijiazhuang No.4 Pharmaceutical Co., Ltd. Corporate Entity 2314.14 5.11
5 Yunnan International Trust Co., Ltd. - Yunnan Trust - Kairui 257 Single Fund Trust Asset Management Plan 902.85 1.99
6 Hong Kong Securities Clearing Company Ltd. Northbound Capital 826.05 1.82
7 Fullgoal Fund - China Life Insurance Company Limited - Traditional Insurance - Fullgoal Fund China Life Shares Growth Stock Traditional Available-for-sale Single Asset Management Plan Asset Management Plan 797.83 1.76
8 Fullgoal Fund - China Life Insurance Company Limited - Participating Insurance - Fullgoal Fund China Life Shares Growth Stock Portfolio Single Asset Management Plan (Available-for-sale) Asset Management Plan 643.09 1.42
9 Ping An Healthcare Hybrid Securities Investment Fund Class A Fund 387.77 0.86
10 Fullgoal New Vitality Flexible Allocation Mixed Initiation Securities Investment Fund Class A Fund 200.19 0.44

5. Concept Sectors

  • Innovative Drugs
  • High-Performance Stocks
  • Pension Funds
  • Tencent Ji'an
  • SSE 580

Remarks

  • Data update date: 2025-09-30
  • Data source: Public market information